Adamis Pharmaceuticals

Adamis Pharmaceuticals Corporation is a specialty biopharmaceutical company headquartered in San Diego, California, focused on the development and commercialization of products in the therapeutic areas of allergy, respiratory diseases, and opioid overdose. The company’s product portfolio includes Symjepi, a pre-filled syringe for the emergency treatment of acute allergic reactions, including anaphylaxis. Additionally, Adamis is working on various inhaler products such as fluticasone and beclomethasone for asthma treatment, along with a naloxone injection candidate aimed at addressing opioid overdose. The company also explores treatments for erectile dysfunction and offers a range of other pharmaceutical products, including corticosteroids and hormone replacement therapies. Through its commitment to addressing significant unmet medical needs, Adamis Pharmaceuticals aims to enhance patient outcomes across multiple health conditions.